{"DataElement":{"publicId":"981","version":"4","preferredName":"Participating Group Name","preferredDefinition":"The name of the Cooperative Group working on the clinical protocol.","longName":"PARTIC_GP_NAME","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2188721","version":"1","preferredName":"Participating Group Identifier","preferredDefinition":"information related to participating group identifier.","longName":"PARTIC_GP_ID","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206563","version":"1","preferredName":"Participating Group","preferredDefinition":"Taking part in an activity.:Groups of individuals united by a common factor e.g. geographic location, ethnicity, disease, age, gender, etc.","longName":"C25608:C17005","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Participation","conceptCode":"C25608","definition":"The act of taking part in an activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Population Group","conceptCode":"C17005","definition":"A group of individuals united by a common factor (e.g., geographic location, ethnicity, disease, age, gender)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FA11-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222848","version":"1","preferredName":"Identifier","preferredDefinition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62113C1-8528-4E73-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E54DC7BD-1C8A-6049-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2016487","version":"4","preferredName":"Group Name","preferredDefinition":"name of the Cooperative Group working on the clinical protocol.","longName":"GP_NAME","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"22","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"CALGB","valueDescription":"Cancer and Leukemia Group B","ValueMeaning":{"publicId":"2563898","version":"1","preferredName":"Cancer and Leukemia Group B","longName":"2563898","preferredDefinition":"Cancer and Leukemia Group B","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer and Leukemia Group B","conceptCode":"C25442","definition":"A national clinical research group - network of 29 university medical centers, over 185 community hospitals and more than almost 3000 physicians - sponsored by the NCI, with its Central Office headquartered at the University of Chicago, and its Statistical Center located at Duke University, founded in 1955 with a goal of bringing together clinical and laboratory research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6A7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DD78-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"ECOG","valueDescription":"Eastern Cooperative Oncology Group","ValueMeaning":{"publicId":"2563899","version":"1","preferredName":"Eastern Cooperative Oncology Group","longName":"2563899","preferredDefinition":"Eastern Cooperative Oncology Group","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eastern Cooperative Oncology Group","conceptCode":"C25491","definition":"A cooperative group funded primarily by the NCI, one of the largest clinical cancer research organizations in the US, incorporating universities, medical centers, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs with almost 6000 physicians, nurses, pharmacists, statisticians, and clinical research associates from the US, Canada, and South Africa. ECOG has more than 90 active clinical trials in all types of adult malignancies. Annual accrual is 6,000 patients, with more than 20,000 patients in follow-up.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6A8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DD82-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"NCCTG","valueDescription":"North Central Cancer Treatment Group","ValueMeaning":{"publicId":"2563901","version":"1","preferredName":"North Central Cancer Treatment Group","longName":"2563901","preferredDefinition":"North Central Cancer Treatment Group","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"North Central Cancer Treatment Group","conceptCode":"C25581","definition":"A national clinical research group sponsored by the NCI. The research base for NCCTG is located at Mayo Clinic in Rochester, Minn. NCCTG consists of a network of more than 1,000 cancer specialists at community clinics, hospitals and medical centers in 25 states in US, two Canadian provinces and Mexico. NCCTG specializes in researching methods of treating and preventing cancer, and in researching methods to alleviate the side effects of cancer and cancer treatments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6AA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DD8C-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"RTOG","valueDescription":"Radiation Therapy Oncology Group","ValueMeaning":{"publicId":"2563902","version":"1","preferredName":"Radiation Therapy Oncology Group","longName":"2563902","preferredDefinition":"Radiation Therapy Oncology Group","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy Oncology Group","conceptCode":"C19778","definition":"A multi-institutional cooperative organization, a national cancer study research group comprised of 250 of the major research institutions nationally and in Canada, funded by NCI, headquartered in Philadelphia with almost 30 years of experience in running clinical trials. More than 40 clinical trials that involve radiation therapy either alone or in conjunction with surgery and/or chemotherapeutic drugs are active at any one time within RTOG. The group is interested in quality of life issues and their effects on the cancer patient","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6AB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DD96-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"SWOG","valueDescription":"Southwest Oncology Group","ValueMeaning":{"publicId":"2563897","version":"1","preferredName":"Southwest Oncology Group","longName":"2563897","preferredDefinition":"Southwest Oncology Group","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Southwest Oncology Group","conceptCode":"C25699","definition":"An NCI-sponsored cooperative group, an adult cancer clinical trials organization, one of the largest in the world. The group was established in 1956 and is headquartered in San Antonio, TX. Its network consists of almost 4,000 of the physicians at 283 institutions throughout the US and Canada. The major goal of the SWOG since 1990 has been to enroll more women and minority patients in cancer treatment and control research trials.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6A6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DDA0-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"ACOSOG","valueDescription":"American College of Surgeons Oncology Group","ValueMeaning":{"publicId":"2563900","version":"1","preferredName":"American College of Surgeons Oncology Group","longName":"2563900","preferredDefinition":"American College of Surgeons Oncology Group","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American College of Surgeons Oncology Group","conceptCode":"C19712","definition":"A cooperative group sponsored by the NCI whose primary goal is to evaluate surgical therapies in the management of patients with malignant solid tumors. The ACOSOG (Durham, NC) includes general and specialty surgeons, representatives of related oncologic disciplines and allied health professionals in academic medical centers and community practices throughout the US and foreign countries. The group is composed of the Administrative Coordinating Center and the Statistics and Data Coordinating. Both groups are based at the Duke Clinical Research Institute.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6A9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DDAA-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"COG","valueDescription":"Children's Oncology Group","ValueMeaning":{"publicId":"2563903","version":"1","preferredName":"Children's Oncology Group","longName":"2563903v1.00","preferredDefinition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Oncology Group","conceptCode":"C39353","definition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6AC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SOKKERL","dateModified":"2023-03-01","changeDescription":"Updated to use Current concept C39353 - this one was retired in EVS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DDB4-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"EORTC","valueDescription":"European Organization for Research and Treatment of Cancer","ValueMeaning":{"publicId":"2563904","version":"1","preferredName":"European Organization for Research and Treatment of Cancer","longName":"2563904","preferredDefinition":"European Organization for Research and Treatment of Cancer","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Organization for Research and Treatment of Cancer","conceptCode":"C19741","definition":"A group with aims to conduct, develop, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients' quality of life. There are more than 60 institutions and departments that have been recognized by EORTC as affiliated. These groups conduct, on a voluntary basis, laboratory research and/or clinical trials on all types of cancers using a multidisciplinary approach. EORTC maintains close working relationship with NCI and the British Cancer Research United Kingdom in London.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6AD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DDBE-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"GOG","valueDescription":"Gynecologic Oncology Group","ValueMeaning":{"publicId":"2563905","version":"1","preferredName":"Gynecologic Oncology Group","longName":"2563905","preferredDefinition":"Gynecologic Oncology Group","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gynecologic Oncology Group","conceptCode":"C25521","definition":"A non-profit NCI-supported organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies. Approximately 45 individual clinical trials are active at any one time within GOG.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6AE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DDC8-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"NSABP","valueDescription":"National Surgical Adjuvant Breast and Bowel Project","ValueMeaning":{"publicId":"2563907","version":"1","preferredName":"National Surgical Adjuvant Breast and Bowel Project","longName":"2563907","preferredDefinition":"National Surgical Adjuvant Breast and Bowel Project","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Surgical Adjuvant Breast and Bowel Project","conceptCode":"C15818","definition":"A clinical trials cooperative group supported by the NCI. The group headquarters in Pittsburgh, Pennsylvania and has research sites at nearly 200 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, Puerto Rico, and Australia. In addition to funding from the NCI, which the NSABP has received since it began, the NSABP also receives support from other sources for ancillary studies, training, and educational programs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6B0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DDD2-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"ACRIN","valueDescription":"American College of Radiology Oncologic Imaging Network","ValueMeaning":{"publicId":"2563908","version":"1","preferredName":"American College of Radiology Oncologic Imaging Network","longName":"2563908","preferredDefinition":"American College of Radiology Oncologic Imaging Network","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6B1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"PWEST","dateModified":"2003-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DDDC-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"IBCSG","valueDescription":"International Breast Cancer Study Group","ValueMeaning":{"publicId":"2563912","version":"1","preferredName":"International Breast Cancer Study Group","longName":"2563912","preferredDefinition":"International Breast Cancer Study Group","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Breast Cancer Study Group","conceptCode":"C25530","definition":"A group dedicated to innovative clinical research designed to improve the prognosis of women with breast cancer. Patients and investigators from six continents: Europe, Australia/ New Zealand, Africa, Asia, and North and South America, cooperate by participating in extensive clinical trials in the Adjuvant breast cancer setting. IBCSG has been a pioneer in research into combined hormonal therapy and chemotherapy, timing and duration of Adjuvant Therapies, and Quality of Life of breast cancer patients. (from ibcsg.org)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6B5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DDE6-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"NABTC","valueDescription":"North American Brain Tumor Consortium","ValueMeaning":{"publicId":"2563909","version":"1","preferredName":"North American Brain Tumor Consortium","longName":"2563909","preferredDefinition":"North American Brain Tumor Consortium","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"North American Brain Tumor Consortium","conceptCode":"C37995","definition":"Dedicated to the development and conduct of innovative clinical trials that will ultimately result in a cure for patients with malignant brain tumors. Their goals are 1) to discover new and effective therapies for the treatment of patients with brain tumors, including anti-angiogenesis drugs, differentiating agents, anti-invasive medications, and new molecular agents such as gene therapy; 2) to develop innovative combination strategies to enhance the therapeutic effects of chemotherapy and radiation treatments; and 3) to develop and fund translational research opportunities that will bring exciting new agents and strategies from the laboratory to the clinical setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6B2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DDF0-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"NABTT","valueDescription":"NABTT Brain Tumor Consortium","ValueMeaning":{"publicId":"2563910","version":"1","preferredName":"NABTT Brain Tumor Consortium","longName":"2563910","preferredDefinition":"NABTT Brain Tumor Consortium","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6B3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"PWEST","dateModified":"2003-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DDFA-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"AMC","valueDescription":"AIDS-Associated Malignancies Clinical Trials Consortium","ValueMeaning":{"publicId":"2563911","version":"1","preferredName":"AIDS-Associated Malignancies Clinical Trials Consortium","longName":"2563911","preferredDefinition":"AIDS-Associated Malignancies Clinical Trials Consortium","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6B4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"PWEST","dateModified":"2003-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE04-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"North American groups","valueDescription":"North American groups (NCCTG, RTOG, CTSU, and NCIC CTG)","ValueMeaning":{"publicId":"3654913","version":"1","preferredName":"North American groups (NCCTG, RTOG, CTSU, and NCIC CTG)","longName":"3654913","preferredDefinition":"North American groups (NCCTG, RTOG, CTSU, and NCIC CTG)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D40D3734-3D73-A7BF-E040-BB89AD4342BB","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE0E-649F-E053-F662850AC973","beginDate":"2013-01-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"RCI BMT","valueDescription":"RCI BMT","ValueMeaning":{"publicId":"3158593","version":"1","preferredName":"RCI BMT","longName":"3158593","preferredDefinition":"Resource for Clinical Investigations in Blood & Marrow Transplant group","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94B70EA8-E6C9-BC28-E040-BB89AD4345D7","latestVersionIndicator":"Yes","beginDate":"2010-11-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-11-10","modifiedBy":"KUMMEROA","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":"2023.5.11 Add Alt VM per KM. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE18-649F-E053-F662850AC973","beginDate":"2010-12-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"BMT CTN","valueDescription":"BMT CTN","ValueMeaning":{"publicId":"3158594","version":"1","preferredName":"BMT CTN","longName":"3158594","preferredDefinition":"Blood & Marrow Transplant Clinical Trials Network group","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94B70EA8-E6EC-BC28-E040-BB89AD4345D7","latestVersionIndicator":"Yes","beginDate":"2010-11-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE22-649F-E053-F662850AC973","beginDate":"2010-12-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE2C-649F-E053-F662850AC973","beginDate":"2010-12-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Non-CALGB","valueDescription":"Non-CALGB","ValueMeaning":{"publicId":"3693831","version":"1","preferredName":"Non-CALGB","longName":"3693831","preferredDefinition":"Any non-CALGB institution","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D758DAD1-519E-2030-E040-BB89AD430853","latestVersionIndicator":"Yes","beginDate":"2013-03-07","endDate":null,"createdBy":"LEUNGE","dateCreated":"2013-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE36-649F-E053-F662850AC973","beginDate":"2013-03-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"USIDNET","valueDescription":"United States Immunodeficiency Network","ValueMeaning":{"publicId":"3950371","version":"1","preferredName":"United States Immunodeficiency Network","longName":"3950371","preferredDefinition":"A research consortium established to advance scientific research in the primary immune deficiency diseases (PIDD).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"United States Immunodeficiency Network","conceptCode":"C88717","definition":"A research consortium established to advance scientific research in the primary immune deficiency diseases (PIDD).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EAB2BBF5-576D-DA98-E040-BB89AD4350E1","latestVersionIndicator":"Yes","beginDate":"2013-11-08","endDate":null,"createdBy":"PWEST","dateCreated":"2013-11-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE40-649F-E053-F662850AC973","beginDate":"2013-11-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"NRG","valueDescription":"NRG Oncology","ValueMeaning":{"publicId":"3950372","version":"1","preferredName":"NRG Oncology","longName":"3950372","preferredDefinition":"NRG Oncology","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EAB2BBF5-5790-DA98-E040-BB89AD4350E1","latestVersionIndicator":"Yes","beginDate":"2013-11-08","endDate":null,"createdBy":"PWEST","dateCreated":"2013-11-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE4A-649F-E053-F662850AC973","beginDate":"2013-11-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Alliance","valueDescription":"Alliance for Clinical Trials in Oncology","ValueMeaning":{"publicId":"3950373","version":"1","preferredName":"Alliance for Clinical Trials in Oncology","longName":"3950373","preferredDefinition":"Alliance for Clinical Trials in Oncology","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EAB2BBF5-57B3-DA98-E040-BB89AD4350E1","latestVersionIndicator":"Yes","beginDate":"2013-11-08","endDate":null,"createdBy":"PWEST","dateCreated":"2013-11-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE54-649F-E053-F662850AC973","beginDate":"2013-11-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"NCIC CTG","valueDescription":"National Cancer Institute of Canada Clinical Trials Group","ValueMeaning":{"publicId":"2563906","version":"1","preferredName":"National Cancer Institute of Canada Clinical Trials Group","longName":"2563906","preferredDefinition":"National Cancer Institute of Canada Clinical Trials Group","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Cancer Institute of Canada Clinical Trials Group","conceptCode":"C39467","definition":"A cooperative oncology group which carries out clinical trials in cancer therapy and supportive care across Canada and internationally. It is supported by the National Cancer Institute of Canada with funds raised by the Canadian Cancer Society.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C6AF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-01-07","endDate":null,"createdBy":"PWEST","dateCreated":"2003-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE5E-649F-E053-F662850AC973","beginDate":"2003-01-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"North American groups","valueDescription":"North American groups (Alliance, ECOG-ACRIN, NRG, SWOG, and NCIC CTG)","ValueMeaning":{"publicId":"4261511","version":"1","preferredName":"North American groups (Alliance, ECOG-ACRIN, NRG, SWOG, and NCIC CTG)","longName":"4261511","preferredDefinition":"North American groups (Alliance, ECOG-ACRIN, NRG, SWOG, and NCIC CTG)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F613DA24-4D48-CF1E-E040-BB89AD435D70","latestVersionIndicator":"Yes","beginDate":"2014-04-02","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE68-649F-E053-F662850AC973","beginDate":"2014-04-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Corporate / Industry","valueDescription":"Corporate / Industry","ValueMeaning":{"publicId":"5084251","version":"1","preferredName":"Corporate / Industry","longName":"5084251","preferredDefinition":"An organization formed with state governmental approval to act as an artificial person to carry on business (or other activities), which can sue or be sued, and (unless it is non-profit) can issue shares of stock to raise funds with which to start a business or increase its cap: Used to indicate that either or both of two items or options may be valid.: The people or companies engaged in a particular kind of commercial enterprise; the organized action of making of goods and services for sale.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Corporation","conceptCode":"C54132","definition":"An organization formed with state governmental approval to act as an artificial person to carry on business (or other activities), which can sue or be sued, and (unless it is non-profit) can issue shares of stock to raise funds with which to start a business or increase its cap","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Industry","conceptCode":"C25181","definition":"The people or companies engaged in a particular kind of commercial enterprise; the organized action of making of goods and services for sale.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26DE3726-ACE9-9948-E050-BB89AD430859","latestVersionIndicator":"Yes","beginDate":"2015-12-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2015-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE72-649F-E053-F662850AC973","beginDate":"2015-12-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"EudraCT","valueDescription":"European Union Drug Regulating Authorities Clinical Trials Database","ValueMeaning":{"publicId":"5731843","version":"1","preferredName":"European Union Drug Regulating Authorities Clinical Trials Database","longName":"5731843","preferredDefinition":"The European Union's electronic database of clinical trials. It contains information submitted by sponsors and informs users about ongoing clinical trials in EU Member States and European Economic Area countries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"European Union Drug Regulating Authorities Clinical Trials Database","conceptCode":"C132782","definition":"The European Union's electronic database of clinical trials. It contains information submitted by sponsors and informs users about ongoing clinical trials in EU Member States and European Economic Area countries.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C4840BF-B968-4697-E053-F662850A3458","latestVersionIndicator":"Yes","beginDate":"2017-04-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-04-03","modifiedBy":"DWARZEL","dateModified":"2018-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE7C-649F-E053-F662850AC973","beginDate":"2017-04-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"UMIN","valueDescription":"University Medical Information Network","ValueMeaning":{"publicId":"5731842","version":"1","preferredName":"University Medical Information Network","longName":"5731842","preferredDefinition":"A cooperative organization for national medical schools in Japan designed to: provide up-to-date information to healthcare professionals; promote communications between healthcare professionals; support collaborative work among university hospitals; support collaborative medical research; standardize medical data and collect hospital statistics; support education and training at hospitals.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"University Medical Information Network","conceptCode":"C132784","definition":"A cooperative organization for national medical schools in Japan designed to: provide up-to-date information to healthcare professionals; promote communications between healthcare professionals; support collaborative work among university hospitals; support collaborative medical research; standardize medical data and collect hospital statistics; support education and training at hospitals.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C4840BF-B943-4697-E053-F662850A3458","latestVersionIndicator":"Yes","beginDate":"2017-04-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-04-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE86-649F-E053-F662850AC973","beginDate":"2017-04-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Investigator initiated","valueDescription":"Investigator Initiation","ValueMeaning":{"publicId":"5837121","version":"1","preferredName":"Investigator Initiation","longName":"5837121","preferredDefinition":"An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures.  The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject).  The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements.: The act of starting something; an act that sets in motion some course of events.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Investigator","conceptCode":"C25936","definition":"An individual who conducts scientific research. In a clinical setting this individual actually conducts and/or supervises the clinical investigation and study-related procedures.  The investigator monitors the safety of the trial subjects and investigational staff (under whose immediate direction an agent is administered or dispensed to a subject).  The investigator collects and analyses data and study documents, and provides reports in compliance with applicable requirements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Initiation","conceptCode":"C47938","definition":"The act of starting something; an act that sets in motion some course of events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"503391C0-374D-0295-E053-F662850AE09C","latestVersionIndicator":"Yes","beginDate":"2017-05-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-05-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE90-649F-E053-F662850AC973","beginDate":"2017-05-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"North American groups","valueDescription":"North American groups (Alliance, ECOG-ACRIN, NRG, SWOG, and CCTG)","ValueMeaning":{"publicId":"5896941","version":"1","preferredName":"North American groups (Alliance, ECOG-ACRIN, NRG, SWOG, and CCTG)","longName":"5896941","preferredDefinition":"North American groups (Alliance, ECOG-ACRIN, NRG, SWOG, and CCTG)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F75AB2-CE54-58E9-E053-F662850A47B4","latestVersionIndicator":"Yes","beginDate":"2017-07-10","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DE9A-649F-E053-F662850AC973","beginDate":"2017-07-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"Center specific","valueDescription":"Clinical Study Facility","ValueMeaning":{"publicId":"5827894","version":"1","preferredName":"Clinical Study Facility","longName":"5827894","preferredDefinition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.: Services and space and equipment provided for a particular purpose; a building or place that provides a particular service or is used for a particular industry.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Facility","conceptCode":"C62574","definition":"Services and space and equipment provided for a particular purpose; a building or place that provides a particular service or is used for a particular industry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F976041-2E69-4757-E053-F662850A9671","latestVersionIndicator":"Yes","beginDate":"2017-05-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DEA4-649F-E053-F662850AC973","beginDate":"2017-05-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"COGNO","valueDescription":"Clinical Trials Cooperative Group For Neurologic Oncology","ValueMeaning":{"publicId":"6183585","version":"1","preferredName":"Clinical Trials Cooperative Group For Neurologic Oncology","longName":"6183585","preferredDefinition":"A group of researchers, cancer centers, and community doctors who are involved in studies of new cancer treatment, prevention, early detection, quality of life, and rehabilitation. Clinical trials carried out by cooperative groups are sponsored by the National Cancer Institute (NCI), and large numbers of patients take part in many locations. Examples include the Radiation Therapy Oncology Group (RTOG), Gynecologic Oncology Group (GOG), and Children's Oncology Group (COG).: The reason of something.: The branch of oncology concerned with the study, diagnosis, and treatment of cancers of the nervous system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trials Cooperative Group","conceptCode":"C18205","definition":"A group of researchers, cancer centers, and community doctors who provide infrastructure for studies of new cancer treatment, prevention, early detection, quality of life, and rehabilitation. (BRIDG)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neurologic Oncology","conceptCode":"C17854","definition":"The branch of oncology concerned with the study, diagnosis, and treatment of cancers of the nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69916EE6-4064-2CC6-E053-F662850AD033","latestVersionIndicator":"Yes","beginDate":"2018-04-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2018-04-11","modifiedBy":"ONEDATA","dateModified":"2018-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DEAE-649F-E053-F662850AC973","beginDate":"2018-04-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"PIDTC","valueDescription":"Primary Immune Deficiency Treatment Consortium","ValueMeaning":{"publicId":"6352247","version":"1","preferredName":"Primary Immune Deficiency Treatment Consortium","longName":"6352247","preferredDefinition":"A consortium of 42 centers in North America whose shared goal is to improve the outcome of patients with rare, life threatening, inherited disorders of the immune system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Immune Deficiency Treatment Consortium","conceptCode":"C153199","definition":"A consortium of 42 centers in North America whose shared goal is to improve the outcome of patients with rare, life threatening, inherited disorders of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70C7066D-4766-0C53-E053-F662850AB902","latestVersionIndicator":"Yes","beginDate":"2018-07-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2018-07-12","modifiedBy":"ONEDATA","dateModified":"2018-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9454716A-DEB8-649F-E053-F662850AC973","beginDate":"2018-07-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ONEDATA","dateModified":"2019-10-07","deletedIndicator":"No"},{"value":"ANZCTR","valueDescription":"Australia New Zealand Clinical Trial Registry","ValueMeaning":{"publicId":"7480490","version":"1","preferredName":"Australia New Zealand Clinical Trial Registry","longName":"7480490","preferredDefinition":"An online register of clinical trials being undertaken in Australia, New Zealand, and elsewhere. It includes trials for pharmaceuticals, surgical procedures, preventive measures, lifestyle, devices, treatment and rehabilitation strategies, and complementary therapies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Australia New Zealand Clinical Trial Registry","conceptCode":"C175548","definition":"An online register of clinical trials being undertaken in Australia, New Zealand, and elsewhere. It includes trials for pharmaceuticals, surgical procedures, preventive measures, lifestyle, devices, treatment and rehabilitation strategies, and complementary therapies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B298765C-D347-7191-E053-4EBD850A781E","latestVersionIndicator":"Yes","beginDate":"2020-10-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-26","modifiedBy":"ONEDATA","dateModified":"2020-10-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B298765C-D360-7191-E053-4EBD850A781E","beginDate":"2020-10-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-10-26","modifiedBy":"ONEDATA","dateModified":"2020-10-26","deletedIndicator":"No"},{"value":"PedAL","valueDescription":"Childhood Acute Leukemia","ValueMeaning":{"publicId":"8176750","version":"1","preferredName":"Childhood Acute Leukemia","longName":"8176750","preferredDefinition":"An acute leukemia that occurs during childhood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Childhood Acute Leukemia","conceptCode":"C187056","definition":"An acute leukemia that occurs during childhood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD9149F3-696A-6C51-E053-4EBD850AF02D","latestVersionIndicator":"Yes","beginDate":"2022-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-26","modifiedBy":"ONEDATA","dateModified":"2022-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD9149F3-6983-6C51-E053-4EBD850AF02D","beginDate":"2022-04-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-04-26","modifiedBy":"ONEDATA","dateModified":"2022-04-26","deletedIndicator":"No"},{"value":"PTCTC","valueDescription":null,"ValueMeaning":{"publicId":"14073042","version":"1","preferredName":"Pediatric Transplantation and Cellular Therapy Consortium","longName":"14073042v1.00","preferredDefinition":"A clinical trials group focused exclusively on blood and marrow transplants for children and adolescents. It includes more than 100 pediatric centers in the United States, Canada, New Zealand, and Australia, as well as affiliated members in Europe, Asia, and South America.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pediatric Transplantation and Cellular Therapy Consortium","conceptCode":"C200478","definition":"A clinical trials group focused exclusively on blood and marrow transplants for children and adolescents. It includes more than 100 pediatric centers in the United States, Canada, New Zealand, and Australia, as well as affiliated members in Europe, Asia, and South America.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0077286D-B1CD-10CA-E063-731AD00A2A3F","latestVersionIndicator":"Yes","beginDate":"2023-07-14","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-07-14","modifiedBy":"ZHWENDY","dateModified":"2023-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0077286D-B1CE-10CA-E063-731AD00A2A3F","beginDate":"2023-07-14","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2023-07-14","modifiedBy":"ZHWENDY","dateModified":"2023-07-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008527","version":"1","preferredName":"Research Organizations","preferredDefinition":"groups, institutions, or clinical facilities that conduct clinical research or tests, or analyze clinical data.","longName":"RES_ORGS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC94A4-3F0A-3494-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2238450","version":"1","preferredName":"Name","preferredDefinition":"Personal names, given or surname, as cultural characteristics, as ethnological or religious patterns, as indications of the geographic distribution of families and inbreeding, etc. Analysis of isonymy, the quality of having the same or similar names, is useful in the study of population genetics. NAMES is used also for the history of names or name changes of corporate bodies, such as medical societies, universities, hospitals, government agencies, etc.","longName":"C25191","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person Name","conceptCode":"C25191","definition":"A word or group of words indicating the identity of a person usually consisting of a first (personal) name and a last (family) name with an optional middle name. In some cultural traditions the family name comes first.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-181C-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-23","modifiedBy":"ONEDATA","dateModified":"2005-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9454716A-DD62-649F-E053-F662850AC973","latestVersionIndicator":"Yes","beginDate":"2019-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"ZHWENDY","dateModified":"2023-07-14","changeDescription":"updated for ISO compliance; Added new PVs per request to add new NCI Cooperative Groups","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811911","version":"1","longName":"Upper GI","context":"CTEP"},{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"},{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"},{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"},{"publicId":"2811961","version":"1","longName":"Protocol/Admin.","context":"CTEP"},{"publicId":"2811955","version":"1","longName":"Follow-up","context":"CTEP"},{"publicId":"2811959","version":"1","longName":"Patient Char.","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"},{"publicId":"2811951","version":"1","longName":"Adverse Events","context":"CTEP"},{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"},{"publicId":"2811962","version":"1","longName":"Response","context":"CTEP"},{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811952","version":"1","longName":"Cytogenetics","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811786","version":"1","longName":"APL Prev Untreated","context":"CTEP"},{"publicId":"10000362","version":"1","longName":"AML Prev Untreated","context":"CTEP"},{"publicId":"3298577","version":"1","longName":"Hepatobiliary","context":"CTEP"},{"publicId":"10000001","version":"1","longName":"NSCLC Advanced","context":"CTEP"},{"publicId":"2811931","version":"1","longName":"NSCLC Stage I-III","context":"CTEP"},{"publicId":"10000462","version":"1","longName":"Muscle Invasive Blad","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]}],"AlternateNames":[{"name":"0062666","type":"HISTORICAL_CDE_ID","context":"CTEP"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"Participating Group Name","url":null,"context":"CTEP"},{"name":"Participating Group","type":"Preferred Question Text","description":"Participating Group","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"94548CA7-311B-64A8-E053-F662850AF9AF","latestVersionIndicator":"Yes","beginDate":"2019-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2019-10-07","modifiedBy":"CAMPBELB","dateModified":"2019-10-07","changeDescription":"updated for ISO compliance; changes included from Header Committee","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}